With regard to regulation of oxidative stress in glioma, besides the aforementioned antioxidant and non-antioxidant enzymes, Nrf2 and HIF-1α are few among the validated targets for therapy (Godoy et al., 2020). The gene discussed is HIF1A; the disease is central nervous system cancer.